COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector

Infection Viral Clinical Trial

— SEROCO  

Official title:

Study of the COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector in 3 French Regions Facing the COVID-19 Epidemic With Varying Degrees of Intensity

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04481529
• Other study ID #: 87RI20_0049/SEROCO
• Status: Active, not recruiting
• Start date: July 29, 2020
• Est. completion date: January 15, 2021

Study information

• Verified date: November 2020
• Source: University Hospital, Limoges
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Hospital staff, on the front line in the COVID-19 crisis, have many questions about the risk that they have been infected with this potentially fatal virus. These questions of course primarily concern caregivers working in sectors dedicated to COVID-19 patients, whether they are resuscitating or not, but also those in non-COVID-19 sectors, or even staff without direct contact with patients. In addition, depending on the suddenness and intensity of this "COVID-19 wave", these personnel have been more or less trained and sometimes exposed due to the dire lack of protective equipment. In some countries such as Great Britain, this has resulted in significant absenteeism, a source of deepening the shortage of caregivers.

This proportion of contaminated caregivers has not been evaluated on the whole of French territory. Studies from other countries suggest figures ranging from 1.5% in China to 20% in Italy. It is therefore impossible to rely on such variable data to have a reliable estimate.

Since june 2020, all staff in French health establishments could benefit a serological test.

Thus, in this epidemiological study, we propose to rely on this institutional serological screening to describe the link between seroconversion of hospital staff, regional intensity of the epidemic, and sectors of activity (COVID-19 sectors, non-COVID-19 caregivers , non-COVID-19 non-caregivers.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 1576
• Est. completion date: January 15, 2021
• Est. primary completion date: December 15, 2020
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Hospital staff from Argenteuil, Belfort, Dijon and Limoges hospitals.

• Age = 18 years old

• Participation agreement

Exclusion Criteria:

• Protected persons

• Refusal of participation

Related Conditions & MeSH terms

• Infection Viral
• Virus Diseases

Intervention

Other:
• Health Questionnaire
Completion of a short questionnaire noting the result of the serology and looking for elements in favor of exposure to the virus, whether professional or extra-professional.

Locations

Country	Name	City	State
France	CH Argenteuil - Service de Réanimation	Argenteuil
France	Ch Belfort	Belfort
France	CHU Dijon - Serve de Réanimation	Dijon
France	CHU de Limoges	Limoges

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Limoges

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of subjects with a COVID-19 seroconversion	Number of subjects with a COVID-19 seroconversion fixed by the presence of IgG + in serology according to the service (COVID19 +, COVID19- caregiver, COVID- non-caregiver).	through study completion, an average of 5 month